Showing results (21-30 of 64) with videos related to
Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|February 1, 1996
Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococciS K Spangler, M R Jacobs, P C AppelbaumEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1990
Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazoleM R Jacobs, S K Spangler, P C AppelbaumEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1993
Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococciS K Spangler, M R Jacobs, P C AppelbaumAntimicrobial Agents and Chemotherapy|April 1, 1994
Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycinS K Spangler, M R Jacobs, P C AppelbaumAntimicrobial Agents and Chemotherapy|October 1, 1994
Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobesS K Spangler, M R Jacobs, P C AppelbaumAntimicrobial Agents and Chemotherapy|November 1, 1994
Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteriaS K Spangler, M R Jacobs, P C AppelbaumAntimicrobial Agents and Chemotherapy|June 1, 1991
Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agentsP C Appelbaum, S K Spangler, M R JacobsAntimicrobial Agents and Chemotherapy|December 22, 1999
Postantibiotic effects of grepafloxacin compared to those of five other agents against 12 gram-positive and -negative bacteriaS K Spangler, S Bajaksouzian, M R Jacobs, et al.Trends in Biochemical Sciences|February 14, 2025
A wrinkle in timers: evolutionary rewiring of conserved biological timekeepersRebecca K Spangler, Keya Jonnalagadda, Jordan D Ward, et al.Journal of Clinical Microbiology|January 1, 1988
Survival of bacteria in Difco CultureSwab and Marion Culturette II transport systemsP C Appelbaum, S K Spangler, R Crist, et al.Pageof 7